OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The Critical Contribution of Pseudouridine to mRNA COVID-19 Vaccines
Pedro Morais, Hironori Adachi, Yi‐Tao Yu
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 175
Pedro Morais, Hironori Adachi, Yi‐Tao Yu
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 175
Showing 1-25 of 175 citing articles:
mRNA-based therapeutics: powerful and versatile tools to combat diseases
Shugang Qin, Xiaoshan Tang, Yu‐Ting Chen, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 384
Shugang Qin, Xiaoshan Tang, Yu‐Ting Chen, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 384
Chemistry, structure and function of approved oligonucleotide therapeutics
Martin Egli, Muthiah Manoharan
Nucleic Acids Research (2023) Vol. 51, Iss. 6, pp. 2529-2573
Open Access | Times Cited: 370
Martin Egli, Muthiah Manoharan
Nucleic Acids Research (2023) Vol. 51, Iss. 6, pp. 2529-2573
Open Access | Times Cited: 370
RNA modifications: importance in immune cell biology and related diseases
Lian Cui, Rui Ma, Jiangluyi Cai, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 177
Lian Cui, Rui Ma, Jiangluyi Cai, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 177
Targeting cancer with mRNA–lipid nanoparticles: key considerations and future prospects
Edo Kon, Nitay Ad‐El, Inbal Hazan‐Halevy, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 11, pp. 739-754
Open Access | Times Cited: 127
Edo Kon, Nitay Ad‐El, Inbal Hazan‐Halevy, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 11, pp. 739-754
Open Access | Times Cited: 127
Regulation and functions of non-m6A mRNA modifications
Hanxiao Sun, Kai Li, Cong Liu, et al.
Nature Reviews Molecular Cell Biology (2023) Vol. 24, Iss. 10, pp. 714-731
Closed Access | Times Cited: 122
Hanxiao Sun, Kai Li, Cong Liu, et al.
Nature Reviews Molecular Cell Biology (2023) Vol. 24, Iss. 10, pp. 714-731
Closed Access | Times Cited: 122
Vaccination in patients with kidney failure: lessons from COVID-19
Nina Babel, Christian Hugo, Timm H. Westhoff
Nature Reviews Nephrology (2022) Vol. 18, Iss. 11, pp. 708-723
Open Access | Times Cited: 79
Nina Babel, Christian Hugo, Timm H. Westhoff
Nature Reviews Nephrology (2022) Vol. 18, Iss. 11, pp. 708-723
Open Access | Times Cited: 79
Effect of mRNA-LNP components of two globally-marketed COVID-19 vaccines on efficacy and stability
Lizhou Zhang, Kunal R. More, Amrita Ojha, et al.
npj Vaccines (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 67
Lizhou Zhang, Kunal R. More, Amrita Ojha, et al.
npj Vaccines (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 67
US public investment in development of mRNA covid-19 vaccines: retrospective cohort study
Hussain S. Lalani, Sarosh Nagar, Ameet Sarpatwari, et al.
BMJ (2023), pp. e073747-e073747
Open Access | Times Cited: 53
Hussain S. Lalani, Sarosh Nagar, Ameet Sarpatwari, et al.
BMJ (2023), pp. e073747-e073747
Open Access | Times Cited: 53
‘Spikeopathy’: COVID-19 Spike Protein Is Pathogenic, from Both Virus and Vaccine mRNA
Peter Parry, Astrid Lefringhausen, Conny Turni, et al.
Biomedicines (2023) Vol. 11, Iss. 8, pp. 2287-2287
Open Access | Times Cited: 51
Peter Parry, Astrid Lefringhausen, Conny Turni, et al.
Biomedicines (2023) Vol. 11, Iss. 8, pp. 2287-2287
Open Access | Times Cited: 51
CRISPR-Cas-mediated transcriptional modulation: The therapeutic promises of CRISPRa and CRISPRi
Louise Bendixen, Trine I. Jensen, Rasmus O. Bak
Molecular Therapy (2023) Vol. 31, Iss. 7, pp. 1920-1937
Open Access | Times Cited: 50
Louise Bendixen, Trine I. Jensen, Rasmus O. Bak
Molecular Therapy (2023) Vol. 31, Iss. 7, pp. 1920-1937
Open Access | Times Cited: 50
mRNA vaccines: The future of prevention of viral infections?
Piotr Rzymski, Agnieszka Szuster−Ciesielska, Tomasz Dzieciątkowski, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 2
Closed Access | Times Cited: 46
Piotr Rzymski, Agnieszka Szuster−Ciesielska, Tomasz Dzieciątkowski, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 2
Closed Access | Times Cited: 46
RNA modifications in cellular metabolism: implications for metabolism-targeted therapy and immunotherapy
Weiwei Liu, Si-Qing Zheng, Li Tian, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 27
Weiwei Liu, Si-Qing Zheng, Li Tian, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 27
Breaking the mold with RNA—a “RNAissance” of life science
Charles H. Jones, John R. Androsavich, N. So, et al.
npj Genomic Medicine (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 16
Charles H. Jones, John R. Androsavich, N. So, et al.
npj Genomic Medicine (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 16
Critical roles and clinical perspectives of RNA methylation in cancer
Ganglei Li, Qinfan Yao, Peixi Liu, et al.
MedComm (2024) Vol. 5, Iss. 5
Open Access | Times Cited: 16
Ganglei Li, Qinfan Yao, Peixi Liu, et al.
MedComm (2024) Vol. 5, Iss. 5
Open Access | Times Cited: 16
Comparison of DLin-MC3-DMA and ALC-0315 for siRNA Delivery to Hepatocytes and Hepatic Stellate Cells
Francesca Ferraresso, Amy W. Strilchuk, Lih Jiin Juang, et al.
Molecular Pharmaceutics (2022) Vol. 19, Iss. 7, pp. 2175-2182
Open Access | Times Cited: 57
Francesca Ferraresso, Amy W. Strilchuk, Lih Jiin Juang, et al.
Molecular Pharmaceutics (2022) Vol. 19, Iss. 7, pp. 2175-2182
Open Access | Times Cited: 57
Vaccines for COVID-19: A Systematic Review of Immunogenicity, Current Development, and Future Prospects
Zhan Zhang, Qi Shen, Haocai Chang
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 55
Zhan Zhang, Qi Shen, Haocai Chang
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 55
The Pivotal Role of Chemical Modifications in mRNA Therapeutics
Albert Liu, Xiao Wang
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 52
Albert Liu, Xiao Wang
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 52
Ultrasound and nanomaterial: an efficient pair to fight cancer
Edouard Alphandéry
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 40
Edouard Alphandéry
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 40
The mRNA Vaccine Revolution: COVID-19 Has Launched the Future of Vaccinology
Zhongfeng Ye, Joseph F. Harmon, Wei Ni, et al.
ACS Nano (2023) Vol. 17, Iss. 16, pp. 15231-15253
Closed Access | Times Cited: 36
Zhongfeng Ye, Joseph F. Harmon, Wei Ni, et al.
ACS Nano (2023) Vol. 17, Iss. 16, pp. 15231-15253
Closed Access | Times Cited: 36
Tailor made: the art of therapeutic mRNA design
Mihir Metkar, Christopher S. Pepin, Melissa J. Moore
Nature Reviews Drug Discovery (2023) Vol. 23, Iss. 1, pp. 67-83
Closed Access | Times Cited: 36
Mihir Metkar, Christopher S. Pepin, Melissa J. Moore
Nature Reviews Drug Discovery (2023) Vol. 23, Iss. 1, pp. 67-83
Closed Access | Times Cited: 36
mRNA vaccine quality analysis using RNA sequencing
Helen M. Gunter, Senel Idrisoglu, Swati Singh, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 30
Helen M. Gunter, Senel Idrisoglu, Swati Singh, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 30
Epitranscriptomic regulation of cortical neurogenesis via Mettl8-dependent mitochondrial tRNA m3C modification
Feng Zhang, Ki‐Jun Yoon, Daniel Y. Zhang, et al.
Cell stem cell (2023) Vol. 30, Iss. 3, pp. 300-311.e11
Open Access | Times Cited: 27
Feng Zhang, Ki‐Jun Yoon, Daniel Y. Zhang, et al.
Cell stem cell (2023) Vol. 30, Iss. 3, pp. 300-311.e11
Open Access | Times Cited: 27
The rise of epitranscriptomics: recent developments and future directions
Jonas Cerneckis, Guo‐li Ming, Hongjun Song, et al.
Trends in Pharmacological Sciences (2023) Vol. 45, Iss. 1, pp. 24-38
Open Access | Times Cited: 22
Jonas Cerneckis, Guo‐li Ming, Hongjun Song, et al.
Trends in Pharmacological Sciences (2023) Vol. 45, Iss. 1, pp. 24-38
Open Access | Times Cited: 22
COVID-19 mRNA Vaccines: Lessons Learned from the Registrational Trials and Global Vaccination Campaign
M. Nathaniel Mead, Stephanie Seneff, Russ Wolfinger, et al.
Cureus (2024)
Open Access | Times Cited: 13
M. Nathaniel Mead, Stephanie Seneff, Russ Wolfinger, et al.
Cureus (2024)
Open Access | Times Cited: 13
Advances and prospects of mRNA vaccines in cancer immunotherapy
Yixuan Liu, Qijia Yan, Zhaoyang Zeng, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 2, pp. 189068-189068
Closed Access | Times Cited: 12
Yixuan Liu, Qijia Yan, Zhaoyang Zeng, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 2, pp. 189068-189068
Closed Access | Times Cited: 12
